Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease

Published:2015-06-09 Issue:4 Volume:34 Page:447-456
ISSN:0914-8779
Container-title:Journal of Bone and Mineral Metabolism
language:en
Short-container-title:J Bone Miner Metab

Author:

Polyzos Stergios A.^ORCID,Anastasilakis Athanasios D.,Kountouras Jannis,Makras Polyzois,Papatheodorou Athanasios,Kokkoris Panagiotis,Sakellariou Grigorios T.,Terpos Evangelos

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Orthopedics and Sports Medicine,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s00774-015-0687-x.pdf

Reference42 articles.

1. Lazo M, Clark JM (2008) The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 28:339–350

2. Polyzos SA, Kountouras J, Zavos C (2009) Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med 72:299–314

3. Armstrong MJ, Adams LA, Canbay A, Syn WK (2014) Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 59:1174–1197

4. Yilmaz Y (2012) Review article: non-alcoholic fatty liver disease and osteoporosis-clinical and molecular crosstalk. Aliment Pharmacol Ther 36:345–352

5. Musso G, Paschetta E, Gambino R, Cassader M, Molinaro F (2013) Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver. Trends Mol Med 19:522–535

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osteokines in Nonalcoholic Fatty Liver Disease;Current Obesity Reports;2024-09-03

2. In vitro osteoclast differentiation enhanced by hepatocyte supernatants from high-fat diet mice;Biochemistry and Biophysics Reports;2024-09

3. Emerging role of liver-bone axis in osteoporosis;Journal of Orthopaedic Translation;2024-09

4. Bone: A Neglected Endocrine Organ?;Journal of Clinical Medicine;2024-07-02

5. Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe;Frontiers in Endocrinology;2024-03-08